Literature DB >> 25813228

Germline mutations predisposing to non-small cell lung cancer.

Gerald H Clamon1, Aaron D Bossler, Taher Abu Hejleh, Muhammad Furqan.   

Abstract

Lung cancer in multiple first degree relatives had previously been attributed to smoking and to inherited enzymes associated with increased activation of carcinogens in smoke. There was not clear agreement on the significance of the testing methods for lung cancer susceptibility. More recent studies have identified germline mutations associated with lung cancer even in the absence of smoking and other mutations with plausible explanations for their association with lung cancer caused by smoking. At this time, the clinical significance of the various germline mutations for screening and the implications for therapy are not certain. This review summarizes the currently identified germline mutations associated with lung cancer, but this growing area of research will very likely identify further significant mutations as well.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25813228     DOI: 10.1007/s10689-015-9796-x

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  41 in total

1.  Familial lung adenocarcinoma caused by the EGFR V843I germ-line mutation.

Authors:  Kouki Ohtsuka; Hiroaki Ohnishi; Daisuke Kurai; Satsuki Matsushima; Yukio Morishita; Mayumi Shinonaga; Hajime Goto; Takashi Watanabe
Journal:  J Clin Oncol       Date:  2010-12-20       Impact factor: 44.544

2.  Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.

Authors:  Christopher I Amos; Xifeng Wu; Peter Broderick; Ivan P Gorlov; Jian Gu; Timothy Eisen; Qiong Dong; Qing Zhang; Xiangjun Gu; Jayaram Vijayakrishnan; Kate Sullivan; Athena Matakidou; Yufei Wang; Gordon Mills; Kimberly Doheny; Ya-Yu Tsai; Wei Vivien Chen; Sanjay Shete; Margaret R Spitz; Richard S Houlston
Journal:  Nat Genet       Date:  2008-04-02       Impact factor: 38.330

3.  Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients.

Authors:  Nathalie Prim; Michele Legrain; Eric Guerin; Bertrand Mennecier; Noelle Weingertner; Anne-Claire Voegeli; Dominique Guenot; Christine M Maugard; Anne-Elisabeth Quoix; Michele Beau-Faller
Journal:  Eur Respir Rev       Date:  2014-09

4.  Concurrent molecular alterations in tumors with germ line epidermal growth factor receptor T790M mutations.

Authors:  Anish Thomas; Liqiang Xi; Corey A Carter; Arun Rajan; Sean Khozin; Eva Szabo; Phillip A Dennis; Giuseppe Giaccone; Mark Raffeld
Journal:  Clin Lung Cancer       Date:  2013-03-26       Impact factor: 4.785

5.  Genetic epidemiology of cigarette smoke-induced lung disease.

Authors:  Ann G Schwartz
Journal:  Proc Am Thorac Soc       Date:  2012-05

6.  Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer Consortium.

Authors:  Darren R Brenner; Paolo Boffetta; Eric J Duell; Heike Bickeböller; Albert Rosenberger; Valerie McCormack; Joshua E Muscat; Ping Yang; H-Erich Wichmann; Irene Brueske-Hohlfeld; Ann G Schwartz; Michele L Cote; Anne Tjønneland; Søren Friis; Loic Le Marchand; Zuo-Feng Zhang; Hal Morgenstern; Neonila Szeszenia-Dabrowska; Jolanta Lissowska; David Zaridze; Peter Rudnai; Eleonora Fabianova; Lenka Foretova; Vladimir Janout; Vladimir Bencko; Miriam Schejbalova; Paul Brennan; Ioan N Mates; Philip Lazarus; John K Field; Olaide Raji; John R McLaughlin; Geoffrey Liu; John Wiencke; Monica Neri; Donatella Ugolini; Angeline S Andrew; Qing Lan; Wei Hu; Irene Orlow; Bernard J Park; Rayjean J Hung
Journal:  Am J Epidemiol       Date:  2012-09-17       Impact factor: 4.897

7.  Analysis of genetic variants in never-smokers with lung cancer facilitated by an Internet-based blood collection protocol: a preliminary report.

Authors:  Nicolas Girard; Emil Lou; Christopher G Azzoli; Rekha Reddy; Mark Robson; Megan Harlan; Irene Orlow; Yasushi Yatabe; Khedoudja Nafa; Marc Ladanyi; Agnes Viale; Mark G Kris; Gregory Riely; Vincent Miller; Robert J Klein; Keitaro Matsuo; William Pao
Journal:  Clin Cancer Res       Date:  2010-01-12       Impact factor: 12.531

8.  Germ-line mutations in epidermal growth factor receptor (EGFR) are rare but may contribute to oncogenesis: a novel germ-line mutation in EGFR detected in a patient with lung adenocarcinoma.

Authors:  Irene Centeno; Pilar Blay; Iñigo Santamaría; Aurora Astudillo; Ana S Pitiot; Fernando G Osorio; Patricia González-Arriaga; Fernando Iglesias; Primitiva Menéndez; Adonina Tardón; Jose M Freije; Milagros Balbín
Journal:  BMC Cancer       Date:  2011-05-16       Impact factor: 4.430

9.  Novel germline mutation in the transmembrane domain of HER2 in familial lung adenocarcinomas.

Authors:  Hiromasa Yamamoto; Koichiro Higasa; Masakiyo Sakaguchi; Kazuhiko Shien; Junichi Soh; Koichi Ichimura; Masashi Furukawa; Shinsuke Hashida; Kazunori Tsukuda; Nagio Takigawa; Keitaro Matsuo; Katsuyuki Kiura; Shinichiro Miyoshi; Fumihiko Matsuda; Shinichi Toyooka
Journal:  J Natl Cancer Inst       Date:  2013-12-07       Impact factor: 13.506

10.  High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families.

Authors:  Hildur Helgadottir; Veronica Höiom; Göran Jönsson; Rainer Tuominen; Christian Ingvar; Ake Borg; Håkan Olsson; Johan Hansson
Journal:  J Med Genet       Date:  2014-06-16       Impact factor: 6.318

View more
  6 in total

1.  Identification of a rare germline NBN gene mutation by whole exome sequencing in a lung-cancer survivor from a large family with various types of cancer.

Authors:  Makia J Marafie; Mohammed Dashti; Fahd Al-Mulla
Journal:  Fam Cancer       Date:  2017-07       Impact factor: 2.375

2.  A Germline Mutation in ATR Is Associated With Lung Adenocarcinoma in Asian Patients.

Authors:  Guangyao Bao; Xiaojiao Guan; Jie Liang; Yao Yao; Yifan Xiang; Tian Li; Xinwen Zhong
Journal:  Front Oncol       Date:  2022-05-31       Impact factor: 5.738

3.  Lung Cancer Patients with Germline Mutations Detected by Next-Generation Sequencing and/or Liquid Biopsy.

Authors:  Takehito Shukuya; Sandipkumar Patel; Kate Shane-Carson; Kai He; Erin M Bertino; Konstantin Shilo; Gregory A Otterson; David P Carbone
Journal:  J Thorac Oncol       Date:  2017-10-05       Impact factor: 15.609

4.  Diseases and Molecular Diagnostics: A Step Closer to Precision Medicine.

Authors:  Shailendra Dwivedi; Purvi Purohit; Radhieka Misra; Puneet Pareek; Apul Goel; Sanjay Khattri; Kamlesh Kumar Pant; Sanjeev Misra; Praveen Sharma
Journal:  Indian J Clin Biochem       Date:  2017-08-22

Review 5.  Gene aberrations for precision medicine against lung adenocarcinoma.

Authors:  Motonobu Saito; Kouya Shiraishi; Hideo Kunitoh; Seiichi Takenoshita; Jun Yokota; Takashi Kohno
Journal:  Cancer Sci       Date:  2016-05-25       Impact factor: 6.716

Review 6.  Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets.

Authors:  Beatriz Ballester; Javier Milara; Julio Cortijo
Journal:  Int J Mol Sci       Date:  2019-01-30       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.